PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Diabetes Mellitus D003920 90 associated lipids
Dirofilariasis D004184 3 associated lipids
Down Syndrome D004314 18 associated lipids
Dyskinesia, Drug-Induced D004409 15 associated lipids
Edema D004487 152 associated lipids
Encephalitis D004660 15 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Epilepsy, Tonic-Clonic D004830 2 associated lipids
Erythema D004890 22 associated lipids
Fever D005334 35 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Aoun P et al. Neuroprotective effects of PPARgamma agonists against oxidative insults in HT-22 cells. 2003 Eur. J. Pharmacol. pmid:12860474
Rahman A et al. Interactive effect of histamine and prostaglandin D2 on nasal allergic symptoms in rats. 2007 Eur. J. Pharmacol. pmid:17112500
Roy SJ et al. Characterization of C-terminal tail determinants involved in CRTH2 receptor trafficking: identification of a recycling motif. 2010 Eur. J. Pharmacol. pmid:20035740
Arai I et al. Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis. 2004 Eur. J. Pharmacol. pmid:15556157
Siegl PK and Wenger HC Cardiovascular responses to an isosterically modified prostaglandin analog in the anesthetized dog. 1985 Eur. J. Pharmacol. pmid:3899681
Chiang PC et al. Induction of Fas clustering and apoptosis by coral prostanoid in human hormone-resistant prostate cancer cells. 2006 Eur. J. Pharmacol. pmid:16806159
Sugimoto H et al. CRTH2-specific binding characteristics of [3H]ramatroban and its effects on PGD2-, 15-deoxy-Delta12, 14-PGJ2- and indomethacin-induced agonist responses. 2005 Eur. J. Pharmacol. pmid:16256979
Moore PK et al. Effect of fibrinopeptides A and B on human and rat platelet aggregation in vitro. 1988 Eur. J. Pharmacol. pmid:3053211
Hirano Y et al. Synergistic effect of PGD2 via prostanoid DP receptor on TNF-alpha-induced production of MCP-1 and IL-8 in human monocytic THP-1 cells. 2007 Eur. J. Pharmacol. pmid:17307163
Mezei Z et al. Platelet eicosanoids and the effect of captopril in blood pressure regulation. 1997 Eur. J. Pharmacol. pmid:9527508
Horiguchi S et al. Alterations in nociception after intracisternal administration of prostaglandin D2, E2 or F2 alpha to conscious mice. 1986 Eur. J. Pharmacol. pmid:3458588
Tanaka T et al. Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration. 2005 Eur. J. Pharmacol. pmid:15680279
Collin M and Thiemermann C The PPAR-gamma ligand 15-deoxy(delta12,14) prostaglandin J2 reduces the liver injury in endotoxic shock. 2003 Eur. J. Pharmacol. pmid:12969773
Ferreira-Silva V et al. Effects of 15-deoxy-Delta12, 14 prostaglandin J2 and ciglitazone on human cancer cell cycle progression and death: the role of PPARgamma. 2008 Eur. J. Pharmacol. pmid:18054911
Pons F et al. Pro-inflammatory and anti-inflammatory effects of the stable prostaglandin D2 analogue, ZK 118.182. 1994 Eur. J. Pharmacol. pmid:7813544
Jongejan R et al. Effect of epithelial denudation, inflammatory mediators and mast cell activation on the sensitivity of isolated human airways to methacholine. 1991 Eur. J. Pharmacol. pmid:1800116
Featherstone RL et al. Active sensitization of guinea-pig airways in vivo enhances in vivo and in vitro responsiveness. 1988 Eur. Respir. J. pmid:3229483
Neri T et al. Role of NF-kappaB and PPAR-gamma in lung inflammation induced by monocyte-derived microparticles. 2011 Eur. Respir. J. pmid:21148223
Maher SA et al. Prostaglandin D2 and the role of the DP1, DP2 and TP receptors in the control of airway reflex events. 2015 Eur. Respir. J. pmid:25323233
Crea AE et al. Mediator concentrations in bronchoalveolar lavage fluid of patients with mild asymptomatic bronchial asthma. 1992 Eur. Respir. J. pmid:1348480
Brannan JD et al. Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing. 2006 Eur. Respir. J. pmid:16707393
Kohyama T et al. Prostaglandin D2 inhibits fibroblast migration. 2002 Eur. Respir. J. pmid:11998998
Johnston SL et al. Prostaglandin D2-induced bronchoconstriction is mediated only in part by the thromboxane prostanoid receptor. 1995 Eur. Respir. J. pmid:7789486
Genovese T et al. Effect of rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 on bleomycin-induced lung injury. 2005 Eur. Respir. J. pmid:15684285
Nowak D et al. Increased LTB4 metabolites and PGD2 in BAL fluid after methacholine challenge in asthmatic subjects. 1993 Eur. Respir. J. pmid:8386107
Maxwell DL et al. Inhaled nedocromil sodium reduces histamine release from isolated large airway segments of asthmatic subjects in vivo. 1993 Eur. Respir. J. pmid:7693506
Inoue M et al. Interactions between the brain renin-angiotensin system and brain prostanoids in the control of vasopressin secretion. 1990 Exp Brain Res pmid:2073934
Kumar VB et al. Angiogenic effect of laminin involves modulation of cyclooxygenase-2 and prostaglandin levels. 2011 Exp. Biol. Med. (Maywood) pmid:21148739
Lotz C et al. Activation of peroxisome-proliferator-activated receptors α and γ mediates remote ischemic preconditioning against myocardial infarction in vivo. 2011 Exp. Biol. Med. (Maywood) pmid:21163821
Zhuang H et al. Regulation of heme oxygenase expression by cyclopentenone prostaglandins. 2003 Exp. Biol. Med. (Maywood) pmid:12709576
Sasaguri T et al. Prostaglandins A and J arrest the cell cycle of cultured vascular smooth muscle cells without suppression of c-myc expression. 1992 Exp. Cell Res. pmid:1572402
Syed MA et al. Expression of TREM-1 is inhibited by PGD2 and PGJ2 in macrophages. 2010 Exp. Cell Res. pmid:20797396
Hossain MS et al. Stable expression of lipocalin-type prostaglandin D synthase in cultured preadipocytes impairs adipogenesis program independently of endogenous prostanoids. 2012 Exp. Cell Res. pmid:22100987
Rajasingh J and Bright JJ 15-Deoxy-delta12,14-prostaglandin J2 regulates leukemia inhibitory factor signaling through JAK-STAT pathway in mouse embryonic stem cells. 2006 Exp. Cell Res. pmid:16737695
Huang WC et al. Superoxide anion-dependent Raf/MEK/ERK activation by peroxisome proliferator activated receptor gamma agonists 15-deoxy-delta(12,14)-prostaglandin J(2), ciglitazone, and GW1929. 2002 Exp. Cell Res. pmid:12083801
Yagami T et al. Novel binding sites of 15-deoxy-Delta12,14-prostaglandin J2 in plasma membranes from primary rat cortical neurons. 2003 Exp. Cell Res. pmid:14597421
Park KS et al. Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathway. 2004 Exp. Cell Res. pmid:15212945
Kondoh K et al. Inhibition of estrogen receptor beta-mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-Delta(12,14)-prostaglandin J(2)-induced apoptosis in cancer cells. 2007 Exp. Cell Res. pmid:17706193
Richard CL et al. 15-Deoxy-delta(12,14)-prostaglandin J(2) down-regulates CXCR4 on carcinoma cells through PPARgamma- and NFkappaB-mediated pathways. 2007 Exp. Cell Res. pmid:17707368
Honma Y et al. Effects of indomethacin and dexamethasone on mechanical scratching-induced cutaneous barrier disruption in mice. 2006 Exp. Dermatol. pmid:16761958
Maurer M and Church MK Inflammatory skin responses induced by icatibant injection are mast cell mediated and attenuated by H(1)-antihistamines. 2012 Exp. Dermatol. pmid:22142018
Mantel A et al. Aldo-keto reductase 1C3 is overexpressed in skin squamous cell carcinoma (SCC) and affects SCC growth via prostaglandin metabolism. 2014 Exp. Dermatol. pmid:24917395
Nieves A and Garza LA Does prostaglandin D2 hold the cure to male pattern baldness? 2014 Exp. Dermatol. pmid:24521203
Sugimoto M et al. Increased scratching counts depend on a decrease in ability of cutaneous prostaglandin D2 biosynthesis in NC/Nga mice with atopic dermatitis. 2005 Exp. Dermatol. pmid:16274457
Takaoka A et al. Role of scratch-induced cutaneous prostaglandin D production on atopic-like scratching behaviour in mice. 2007 Exp. Dermatol. pmid:17359340
Futaki N et al. Role of prostaglandins on mechanical scratching-induced cutaneous barrier disruption in mice. 2007 Exp. Dermatol. pmid:17518991
Sugimoto M et al. Time course changes of scratching counts, dermatitis symptoms, and levels of cutaneous prostaglandins in NC/Nga mice. 2006 Exp. Dermatol. pmid:17002684
Sugimoto M et al. COX-1 inhibition enhances scratching behaviour in NC/Nga mice with atopic dermatitis. 2006 Exp. Dermatol. pmid:16842596
Mrabet-Dahbi S et al. Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands. 2009 Exp. Dermatol. pmid:19382314
Masoodi M et al. Prostaglandin D production in FM55 melanoma cells is regulated by alpha-melanocyte-stimulating hormone and is not related to melanin production. 2010 Exp. Dermatol. pmid:20482620
King KL et al. Metabolism of arachidonic acid by isolated rabbit ciliary epithelium. 1992 Exp. Eye Res. pmid:1426059
Bito LZ Comparison of the ocular hypotensive efficacy of eicosanoids and related compounds. 1984 Exp. Eye Res. pmid:6370708
Goh Y and Nakajima M Stimulatory effects of prostaglandin D2 analogues on adenylate cyclase in rabbit iris-ciliary body membrane fractions. 1990 Exp. Eye Res. pmid:2249731
Jeon KI et al. Inhibitory effects of PPARγ ligands on TGF-β1-induced CTGF expression in cat corneal fibroblasts. 2015 Exp. Eye Res. pmid:26142957
Keeting PE et al. Rat lens prostaglandin biosynthesis during galactose-induced cataractogenesis. 1986 Exp. Eye Res. pmid:3028846
Kuriyan AE et al. Electrophilic PPARγ ligands inhibit corneal fibroblast to myofibroblast differentiation in vitro: a potentially novel therapy for corneal scarring. 2012 Exp. Eye Res. pmid:22178289
Karimi K et al. Stem cell factor and interleukin-4 increase responsiveness of mast cells to substance P. 2000 Exp. Hematol. pmid:10880748
Nencioni A et al. Cyclopentenone prostaglandins induce caspase activation and apoptosis in dendritic cells by a PPAR-gamma-independent mechanism: regulation by inflammatory and T cell-derived stimuli. 2002 Exp. Hematol. pmid:12225793
Kanbe E et al. DR1-like element in human topoisomerase IIalpha gene involved in enhancement of etoposide-induced apoptosis by PPARgamma ligand. 2003 Exp. Hematol. pmid:12691917
Spannhake EW Down-regulation of canine airway mast cell function following exposure to ozone in vivo. 1996 Mar-Apr Exp. Lung Res. pmid:8706634
Kim BE et al. Involvement of Sox-4 in the cytochrome c-dependent AIF-independent apoptotic pathway in HeLa cells induced by Delta12-prostaglandin J2. 2004 Exp. Mol. Med. pmid:15557816
Ahn SG et al. Sox-4 is a positive regulator of Hep3B and HepG2 cells' apoptosis induced by prostaglandin (PG)A(2) and delta(12)-PGJ(2). 2002 Exp. Mol. Med. pmid:12216117
Kim BE et al. Cytochrome C-dependent Fas-independent apoptotic pathway in HeLa cells induced by delta12-prostaglandin J2. 2003 Exp. Mol. Med. pmid:14508070
Lee KJ et al. Ox-LDL suppresses PMA-induced MMP-9 expression and activity through CD36-mediated activation of PPAR-g. 2004 Exp. Mol. Med. pmid:15665586
Kim HJ et al. 15-Deoxy-delta12,14-PGJ2 inhibits IL-6-induced Stat3 phosphorylation in lymphocytes. 2005 Exp. Mol. Med. pmid:16000871
Zhang HX et al. Alteration of biochemical and pathological properties of TDP-43 protein by a lipid mediator, 15-deoxy-Delta(12,14)-prostaglandin J(2). 2010 Exp. Neurol. pmid:20083106
Mello CF and Oliveira MS Commentary on Kaushik et al.: Prostaglandin D2 is crucial for seizure suppression and postictal sleep. Novel evidence supporting a role for prostanoid receptors in seizure control. 2014 Exp. Neurol. pmid:24814715
Muñoz U et al. The cyclopentenone 15-deoxy-delta(12,14)-prostaglandin J2 inhibits G1/S transition and retinoblastoma protein phosphorylation in immortalized lymphocytes from Alzheimer's disease patients. 2005 Exp. Neurol. pmid:16061222
Thura M et al. GIF-0173 protects against cerebral infarction through DP1 receptor activation. 2009 Exp. Neurol. pmid:19576888
Joachim A and Ruttkowski B Prostaglandin D(2) synthesis in Oesophagostomum dentatum is mediated by cytosolic glutathione S-transferase. 2011 Exp. Parasitol. pmid:21056037
Daugschies A Oesophagostomum dentatum: population dynamics and synthesis of prostanoids by histotropic stages cultured in vitro. 1995 Exp. Parasitol. pmid:8542999
Kaiser L et al. Dirofilaria immitis: do filarial cyclooxygenase products depress endothelium-dependent relaxation in the in vitro rat aorta? 1992 Exp. Parasitol. pmid:1516664
Hamilton RG et al. Dirofilaria immitis: diethylcarbamazine-induced anaphylactoid reactions in infected dogs. 1986 Exp. Parasitol. pmid:3458592
Lotz C et al. Peroxisome-proliferator-activated receptor γ mediates the second window of anaesthetic-induced preconditioning. 2011 Exp. Physiol. pmid:21123361
Norman P DP(2) receptor antagonists in development. 2010 Expert Opin Investig Drugs pmid:20615077
Yang K et al. [Changes of prostaglandin D2,carboxypeptidase A3 and platelet activating factor in guinea pig in anaphylactic shock]. 2012 Fa Yi Xue Za Zhi pmid:22812216
Bishop-Bailey D and Warner TD PPARgamma ligands induce prostaglandin production in vascular smooth muscle cells: indomethacin acts as a peroxisome proliferator-activated receptor-gamma antagonist. 2003 FASEB J. pmid:12897060
Giménez-Bastida JA et al. Roles of 5-lipoxygenase and cyclooxygenase-2 in the biosynthesis of hemiketals E2 and D2 by activated human leukocytes. 2017 FASEB J. pmid:28096231
Wayman NS et al. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. 2002 FASEB J. pmid:12087064
Kalantari P et al. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits HIV-1 transactivating protein, Tat, through covalent modification. 2009 FASEB J. pmid:19299483
Planagumà A et al. The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation. 2005 FASEB J. pmid:15876570
Gilroy DW et al. Inducible cyclooxygenase-derived 15-deoxy(Delta)12-14PGJ2 brings about acute inflammatory resolution in rat pleurisy by inducing neutrophil and macrophage apoptosis. 2003 FASEB J. pmid:14563690
Zernecke A et al. Suppression of endothelial adhesion molecule up-regulation with cyclopentenone prostaglandins is dissociated from IkappaB-alpha kinase inhibition and cell death induction. 2003 FASEB J. pmid:12692090
Hayaishi O Molecular mechanisms of sleep-wake regulation: roles of prostaglandins D2 and E2. 1991 FASEB J. pmid:1907936
Wang P et al. Response of chondrocytes to shear stress: antagonistic effects of the binding partners Toll-like receptor 4 and caveolin-1. 2011 FASEB J. pmid:21715681
Fujitani Y et al. Pronounced adipogenesis and increased insulin sensitivity caused by overproduction of prostaglandin D2 in vivo. 2010 FEBS J. pmid:20136655
Xiao Y et al. 3T3-L1 adipocyte apoptosis induced by thiazolidinediones is peroxisome proliferator-activated receptor-gamma-dependent and mediated by the caspase-3-dependent apoptotic pathway. 2010 FEBS J. pmid:20050918
Coyle AT et al. 15-deoxy Delta12,14-prostaglandin J2 suppresses transcription by promoter 3 of the human thromboxane A2 receptor gene through peroxisome proliferator-activated receptor gamma in human erythroleukemia cells. 2005 FEBS J. pmid:16156795
Jakob S and Lovell-Badge R Sex determination and the control of Sox9 expression in mammals. 2011 FEBS J. pmid:21281448
Suganami A et al. Human DP and EP2 prostanoid receptors take on distinct forms depending on the diverse binding of different ligands. 2016 FEBS J. pmid:27636113
Faveeuw C et al. Peroxisome proliferator-activated receptor gamma activators inhibit interleukin-12 production in murine dendritic cells. 2000 FEBS Lett. pmid:11119715
Kim IK et al. Prostaglandin A2 and delta 12-prostaglandin J2 induce apoptosis in L1210 cells. 1993 FEBS Lett. pmid:8477853
Sugiyama H et al. Peroxisome proliferator-activated receptors are expressed in mouse bone marrow-derived mast cells. 2000 FEBS Lett. pmid:10675550
Waku T et al. Atomic structure of mutant PPARgamma LBD complexed with 15d-PGJ2: novel modulation mechanism of PPARgamma/RXRalpha function by covalently bound ligands. 2009 FEBS Lett. pmid:19101554
Koinuma S et al. The resetting of the circadian rhythm by Prostaglandin J2 is distinctly phase-dependent. 2009 FEBS Lett. pmid:19111547
Ohinata K et al. Central prostaglandin D(2) stimulates food intake via the neuropeptide Y system in mice. 2008 FEBS Lett. pmid:18258196
Marui N et al. N-myc suppression and cell cycle arrest at G1 phase by prostaglandins. 1990 FEBS Lett. pmid:2226777
Hong HY et al. Up-regulation of heme oxygenase-1 expression through the Rac1/NADPH oxidase/ROS/p38 signaling cascade mediates the anti-inflammatory effect of 15-deoxy-delta 12,14-prostaglandin J2 in murine macrophages. 2008 FEBS Lett. pmid:18291107
Murakami M et al. Eicosanoid generation from antigen-primed mast cells by extracellular mammalian 14-kDa group II phospholipase A2. 1991 FEBS Lett. pmid:1756867
Boyault S et al. 15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways. 2001 FEBS Lett. pmid:11457450